Clinical Trial Update: Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma. [Phase 2]

View source ↗

Summary

A completed Phase 2 trial assessed the safety and tolerability of the G17DT vaccine in patients with colorectal cancer (colorectal adenocarcinoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• G17DT

Snippet

Sponsor: Cancer Advances Inc. | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED